Registry of Hospitalized Patients Treated With Fondaparinux

Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia

NCT01727401 ·Status: TERMINATED ·Phase: PHASE4

Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy

NCT00377091 ·Status: WITHDRAWN ·Phase: PHASE4

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

NCT01444612 ·Status: COMPLETED

Venous Thrombectomy/Thrombolysis Outcome Registry

NCT02113475 ·Status: UNKNOWN

Study to Determine Effective Dosing of Fondaparinux in Obese Persons

NCT00346879 ·Status: WITHDRAWN ·Phase: PHASE1

Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism

NCT01004939 ·Status: COMPLETED

Epidemiology of Venous Thromboembolism

NCT00456196 ·Status: COMPLETED

Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency

NCT00927602 ·Status: TERMINATED ·Phase: PHASE4

Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery

NCT00767559 ·Status: UNKNOWN ·Phase: NA

ARIXTRA® Adherence in SVT Patients.

NCT01691495 ·Status: COMPLETED

Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism

NCT00413374 ·Status: COMPLETED ·Phase: NA

OASIS-6 : The Safety and Efficacy of Fondaparinux Versus Control Therapy in Patients With ST Segment Elevation Acute Myocardial Infarction

NCT00064428 ·Status: COMPLETED ·Phase: PHASE3

Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events

NCT02155491 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).

NCT00038961 ·Status: COMPLETED ·Phase: PHASE3

Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of Enoxaparin

NCT01707732 ·Status: COMPLETED ·Phase: PHASE3

Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)

NCT00443053 ·Status: COMPLETED ·Phase: PHASE3

Fondaparinux in Critically Ill Patients With Renal Failure

NCT01467583 ·Status: COMPLETED ·Phase: PHASE4

Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers

NCT00436787 ·Status: COMPLETED ·Phase: PHASE2

Replication of the RECORD1 Anticoagulant Trial in Healthcare Claims Data

NCT05083455 ·Status: COMPLETED

Hip Fracture Study of GSK576428 (Fondaparinux Sodium)

NCT00320424 ·Status: COMPLETED ·Phase: PHASE3

Determination of Residual Anticoagulatory Effects of Fondaparinux

NCT01101256 ·Status: UNKNOWN

Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.

NCT00555438 ·Status: COMPLETED ·Phase: PHASE4

The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients

NCT00981409 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients

NCT02213978 ·Status: COMPLETED

Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)

NCT00320398 ·Status: COMPLETED ·Phase: PHASE3